- ►annals.org [PDF] JJY Sung, A Barkun, EJ Kuipers, J Mossner, … - Annals of Internal …, 2009 - Am Coll Physicians Background: Use of proton-pump inhibitors in the management of peptic ulcer bleeding is controversial
because discrepant results have been reported in different ethnic groups. ... Objective: To determine
whether intravenous esomeprazole pre- vents recurrent peptic ulcer bleeding better than ... Cited by 9 - Related articles - All 5 versions
[CITATION] Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding
A Table - Ann Intern Med, 2009 - Am Coll Physicians Related articles
E Nikolsky, R Mehran, GW Stone - The American Journal of Cardiology, 2009 - Elsevier Advanced antiplatelet and antithrombotic strategies improve outcomes by achieving significant
reductions in ischemic complications. However, these therapies increase the risk of hemorrhagic
events that have major negative prognostic implications in patients with stable and acute ... Related articles - All 20 versions
CL Saccar - Expert Opin. Drug Metab. Toxicol. - informahealthcare.com Esomeprazole (S-isomer of omeprazole) demonstrates a better pharmacokinetic/pharmacodynamic
profile than the racemic product omeprazole. Esomeprazole's pharmacological activity of gastric
acid secretion is through proton pump inhibition. The pharmacokinetic properties provide ... Related articles - All 6 versions
A Recomendación - gastro.org.mx Guía clínica de diagnóstico y tratamiento de la hemorragia no variceal del tubo digestivo proximal
Tratamiento Coordinador general: Dr. José Ramón Nogueira de Rojas Coordinadora: Dra. Ligia
Grau Cobos. Participantes: Dr. Guillermo Arceo Pérez, Dr. Reyes Betancourt Linares, Dr. ... Related articles
E Biecker, J Heller, V Schmitz, F Lammert, T … - Dtsch …, 2008 - aerzteblatt.lnsdata.de Generelle Betrachtungen Die Inzidenz beträgt etwa 50 auf 100 000 Personen pro Jahr (1). Die
Letalität liegt zwischen 5 und 11 % (2). Die wesentlichen Blutungsquellen sind peptische
Ulze- ra, Ösophagusentzündungen, medikamenteninduzierte Schleimhautschäden, ... Related articles - All 5 versions
MAB Amozurrutia - gastro.org.mx Después de 25 años del lanzamiento al mercado de los inhibidores de bomba de protones
(IBP), cuan- do se calcula que 5% de la población mundial los ingiere en forma regular y cuando
se encuentran asequibles sin prescripción médica, empiezan a ser considerados sus ... Related articles
RG Kulkarni - medscape.com The use of proton-pump inhibitors (PPI) in the management of peptic ulcer bleeding continues
to be investigated, especially with respect to efficacy in different ethnic groups. Ten investigators
affiliated with the Chinese University of Hong Kong report in the Annals of Internal ... Related articles - All 2 versions
S Siragusa, A Malato, LL Coco, V Cigna, G … - HAEMOPHILIA- …, 2008 - assets0.pubget.com The presence of gastrointestinal angiodysplasia (GI-A) can represent an urgent haematological
problem as it produces serious bleeding, which is usually untreatable. It has been recognized
that G-IA frequently occurs in patients with type 2–3 and acquired von Willebrand disease ... Cited by 1 - Related articles - View as HTML - BL Direct - All 4 versions
